J&J Unit Escapes FCA Case Over Alleged Procrit Kickbacks
A biotechnology unit of Johnson & Johnson on Monday dispensed with the remnants of a False Claims Act case alleging kickbacks to doctors who prescribed anemia drug Procrit after the relator...To view the full article, register now.
Already a subscriber? Click here to view full article